These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
318 related items for PubMed ID: 29476764
1. Genetic deletion of CD38 confers post-ischemic myocardial protection through preserved pyridine nucleotides. Boslett J, Helal M, Chini E, Zweier JL. J Mol Cell Cardiol; 2018 May; 118():81-94. PubMed ID: 29476764 [Abstract] [Full Text] [Related]
2. Characterization of CD38 in the major cell types of the heart: endothelial cells highly express CD38 with activation by hypoxia-reoxygenation triggering NAD(P)H depletion. Boslett J, Hemann C, Christofi FL, Zweier JL. Am J Physiol Cell Physiol; 2018 Mar 01; 314(3):C297-C309. PubMed ID: 29187364 [Abstract] [Full Text] [Related]
3. Depletion of NADP(H) due to CD38 activation triggers endothelial dysfunction in the postischemic heart. Reyes LA, Boslett J, Varadharaj S, De Pascali F, Hemann C, Druhan LJ, Ambrosio G, El-Mahdy M, Zweier JL. Proc Natl Acad Sci U S A; 2015 Sep 15; 112(37):11648-53. PubMed ID: 26297248 [Abstract] [Full Text] [Related]
4. Inhibition of CD38 with the Thiazoloquin(az)olin(on)e 78c Protects the Heart against Postischemic Injury. Boslett J, Reddy N, Alzarie YA, Zweier JL. J Pharmacol Exp Ther; 2019 Apr 15; 369(1):55-64. PubMed ID: 30635470 [Abstract] [Full Text] [Related]
16. Cardiomyocyte-specific deletion of Sirt1 gene sensitizes myocardium to ischaemia and reperfusion injury. Wang L, Quan N, Sun W, Chen X, Cates C, Rousselle T, Zhou X, Zhao X, Li J. Cardiovasc Res; 2018 May 01; 114(6):805-821. PubMed ID: 29409011 [Abstract] [Full Text] [Related]
17. Impairment of endothelial-myocardial interaction increases the susceptibility of cardiomyocytes to ischemia/reperfusion injury. Leucker TM, Ge ZD, Procknow J, Liu Y, Shi Y, Bienengraeber M, Warltier DC, Kersten JR. PLoS One; 2013 May 01; 8(7):e70088. PubMed ID: 23894596 [Abstract] [Full Text] [Related]
18. Attenuation of myocardial ischemia/reperfusion injury by superinduction of inducible nitric oxide synthase. Kanno S, Lee PC, Zhang Y, Ho C, Griffith BP, Shears LL, Billiar TR. Circulation; 2000 Jun 13; 101(23):2742-8. PubMed ID: 10851213 [Abstract] [Full Text] [Related]
20. Clematichinenoside attenuates myocardial infarction in ischemia/reperfusion injury both in vivo and in vitro. Zhang R, Fang W, Han D, Sha L, Wei J, Liu L, Li Y. Planta Med; 2013 Sep 13; 79(14):1289-97. PubMed ID: 23929248 [Abstract] [Full Text] [Related] Page: [Next] [New Search]